The use of short-acting bronchodilators and cost burden of asthma across Global Initiative for Asthma–based severity levels: Insights from a large US commercial and managed Medicaid population-Reference-Cited by-同舟云学术

The use of short-acting bronchodilators and cost burden of asthma across Global Initiative for Asthma–based severity levels: Insights from a large US commercial and managed Medicaid population

Published:2022-08 Issue:8 Volume:28 Page:881-891
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Pollack Michael¹,Gandhi Hitesh¹,Tkacz Joseph²,Lanz Miguel³,Lugogo Njira⁴,Gilbert Ileen¹

Affiliation:

1. BioPharmaceuticals Medical - USA, AstraZeneca, Wilmington, DE.

2. Life Sciences, IBM Watson Health, Cambridge, MA, now with Inovalon, Bowie, MD.

3. Allergy and Asthma, AAADRS Clinical Research Center, Coral Gables, FL.

4. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Reference29 articles.

1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

3. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme

4. 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group

5. The Cost of Persistent Asthma in Europe: An International Population-Based Study in Adults

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asthma control in the United States;Annals of Allergy, Asthma & Immunology;2024-09

2. Patterns of Rescue and Maintenance Medication Claims Surrounding an Asthma Exacerbation in Patients Treated as Intermittent or Mild Persistent Asthma;Journal of Asthma and Allergy;2024-09

3. A Fully Decentralized Randomized Controlled Study of As-Needed Albuterol–Budesonide Fixed-Dose Inhaler in Mild Asthma: The BATURA Study Design;Journal of Asthma and Allergy;2024-08

4. The Use of Albuterol/Budesonide as Reliever Therapy to Reduce Asthma Exacerbations;The Journal of Allergy and Clinical Immunology: In Practice;2024-04

5. Cost-effectiveness of budesonide-formoterol vs inhaled epinephrine in US adults with mild asthma;Annals of Allergy, Asthma & Immunology;2024-02